Skip to Main Content

Paper Details

A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma.
Oncologist
1
2024
Author NameAffiliation
Toni K ChoueiriDana-Farber Cancer Institute
  • 1 - 1

Datasets

Release 1.2